Rep. April McClain Delaney has filed another Periodic Transaction Report showing a purchase of Entegris, Inc. (ENTG) stock, this time made on behalf of one of her dependent children. The transaction, dated July 30, 2026, falls in the disclosed range of $1,001 to $15,000 and is logged in our system as a congress buy signal.
This is not the first time ENTG has shown up in Delaney’s filings. Back in early July, a similar purchase by a dependent was disclosed, as we covered in April McClain Delaney’s Dependent Buys Entegris (ENTG) Stock. Two separate buys of the same semiconductor materials company within a few weeks is the kind of pattern that tends to catch the attention of anyone scanning what stocks politicians are buying, even when there is no indication of coordination or any wrongdoing involved.
An Insider Sale on the Other Side
What makes this filing more interesting is the timing relative to activity inside Entegris itself. Company insider Robert A. Bruggeworth sold shares of ENTG on August 3, 2026, according to a separate disclosure, with the transaction listed at $0 in reported value. That sale landed within roughly a week of the Delaney household’s purchase and well inside the 30-day window that often gets flagged when insider and congressional trading activity in the same stock overlap.
To be clear, there is nothing in the public record connecting these two filings beyond the ticker and the calendar. STOCK Act disclosures exist precisely so that trades like this are visible to the public, and filing one is a legal obligation for members of Congress, not a signal of misconduct. Insider sales by corporate executives are routine and can be driven by anything from portfolio rebalancing to pre-scheduled trading plans. Still, the near-simultaneous appearance of a congressional buy and an executive sale in the same small-cap semiconductor name is exactly the kind of cross-signal that readers building their own pelosi stock tracker reddit-style spreadsheets like to note.
Entegris makes materials and process solutions used in semiconductor manufacturing, a sector that has drawn steady attention from both lawmakers and their household members over the past year. Whether this second purchase reflects renewed conviction in the stock, a scheduled investment plan, or simple coincidence is not something the filing itself answers. What it does confirm is that Entegris has now appeared twice in Delaney’s disclosures within a short span, alongside insider selling activity that overlapped almost to the day.
We will continue tracking any further filings tied to April McClain Delaney or Entegris as they become public.